| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 | ||||
| 2. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 | ||||
| 3. | Re-Rising of Total Bilirubin Level after Postoperative Day 3 (The V Pattern) Predicting Liver Failure and Survival of Patients who Underwent Hepatectomy for Cholangiocarcinoma | Sawangkajohn, W. Luvira, V. Leeratanakachorn, N. Tipwaratorn, T. Theerakul, S. Jarearnrat, A. Titapun, A. Srisuk, T. Pugkhem, A. Khuntikeo, N. Bhudhisawasdi, V. Kamsa-Ard, S. |
2020 | ||||
| 4. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Ravinnipa Chanakankun Tanakorn Proungvitaya Daraporn Chua-On Temduang Limpaiboon Sittiruk Roytrakul Apinya Jusakul Attapol Titapun Apiwat Jarearnrat Siriporn Proungvitaya |
2020 | ||||
| 5. | Serum IgG as a Marker for -Associated Cholangiocarcinoma Correlated with HER2 Overexpression. | Titapun, A Techasen, A Sa-Ngiamwibool, P Sithithaworn, P Luvira, V Srisuk, T Jareanrat, A Dokduang, H Loilome, W Thinkhamrop, B Khuntikeo, N |
2020 | ||||
| 6. | Serum IgG as a Marker for Opisthorchis viverrini-Associated Cholangiocarcinoma Correlated with HER2 Overexpression | Attapol Titapun Anchalee Techasen Prakasit Sa-Ngiamwibool Paiboon Sithithaworn Vor Luvira Tharatip Srisuk Apiwat Jareanrat Hasaya Dokduang Watcharin Loilonne Bandit Thinkhamrop Narong Khuntikeo |
2020 | ||||
| 7. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 | ||||
| 8. | High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection | Attapol Titapun Vor Luvira Tharatip Srisuk Apiwat Jareanrat Vasin Thanasukarn Malinee Thanee Prakasit Sa-Ngiamwibool Sureerat Padthaisong Kassaporn Duangkumpha Manida Suksawat Watcharin Loilome Paiboon Sithithaworn Anchalee Techasen Bandit Thinkhamrop Alexa Dzienny Ayse Caglayan David Park Simran Mahmud Narong Khuntikeo |
2021 | ||||
| 9. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma. | Natwutpong Leeratanakachorn Vor Luvira Theerawee Tipwaratorn Suapa Theeragul Apiwat Jarearnrat Attapol Titapun Tharatip Srisuk Supot Kamsa-ard Ake Pugkhem Narong Khuntikeo Chawalit Pairojkul Vajarabhongsa Bhudhisawasdi |
2021 | ||||
| 10. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma | Padthaisong, S Phetcharaburanin, J Klanrit, P Li, JV Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Wangwiwatsin, A Mahalapbutr, P Loilome, W |
2021 | ||||
| 11. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 | ||||
| 12. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 | ||||
| 13. | Benign Diseases Masquerading as Cholangiocarcinoma: Can we Differentiate before Surgery? | Wannasri, T. Luvira, V. Wongwattanachai, A. Titapun, A. Srisuk, T. Kamsa-Ard, S. Tipwaratorn, T. Theeragul, S. Pugkhem, A. Jarearnrat, A. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2022 | ||||
| 14. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Sitthirak, S Suksawat, M Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sangkhamanon, S Loilome, W |
2022 | ||||
| 15. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 | ||||
| 16. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 | ||||
| 17. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Loilome, W Wee, A Koonmee, S |
2022 | ||||
| 18. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 | ||||
| 19. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 | ||||
| 20. | Compliance with enhanced recovery after surgery predicts long-term outcome after hepatectomy for cholangiocarcinoma. | Jongkatkorn, C Luvira, V Suwanprinya, C Piampatipan, K Leeratanakachorn, N Tipwaratorn, T Titapun, A Srisuk, T Theeragul, S Jarearnrat, A Thanasukarn, V Pugkhem, A Khuntikeo, N Pairojkul, C Kamsa-Ard, S Bhudhisawasdi, V |
2023 | Count | 10 | 16 | 9 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 |
OncoTargets and Therapy (11), pp. 7019-7029 |
||||||||
| 2. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Klanrit, Phetcharaburanin, J. Khuntikeo, N. Titapun, A. Techasen, A. Loilome, |
2019 |
PLoS ONE 9 (14), pp. |
||||||||
| 3. | Re-Rising of Total Bilirubin Level after Postoperative Day 3 (The V Pattern) Predicting Liver Failure and Survival of Patients who Underwent Hepatectomy for Cholangiocarcinoma | Sawangkajohn, W. Luvira, V. Leeratanakachorn, N. Tipwaratorn, T. Theerakul, S. Jarearnrat, A. Titapun, A. Srisuk, T. Pugkhem, A. Khuntikeo, N. Bhudhisawasdi, V. Kamsa-Ard, S. |
2020 |
Asian Pacific Journal of Cancer Prevention 12 (21), pp. 3573-3578 |
||||||||
| 4. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Jusakul, A. Titapun, A. Patrakitkomjorn, S. |
2020 |
Oncology Letters 1 (19), pp. 930-942 |
||||||||
| 5. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma | Titapun, A. Kamsa-Ard, S. Pugkhem, A. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2021 |
International Journal of Hepatology (2021), pp. |
||||||||
| 6. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 |
Frontiers in Public Health (9), pp. |
||||||||
| 7. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Dokduang, H. Padthaisong, S. Namwat, N. Klanrit, P. Phetcharaburanin, J. Wangwiwatsin, A. Khampitak, T. Koonmee, S. Titapun, A. Khuntikeo, N. Loilome, W. |
2021 |
Frontiers in Pharmacology (12), pp. |
||||||||
| 8. | Benign Diseases Masquerading as Cholangiocarcinoma: Can we Differentiate before Surgery? | Wannasri, T. Luvira, V. Wongwattanachai, A. Titapun, A. Srisuk, T. Kamsa-Ard, S. Tipwaratorn, T. Theeragul, S. Pugkhem, A. Jarearnrat, A. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2022 |
Asian Pacific Journal of Cancer Care 4 (7), pp. 621-628 |
||||||||
| 9. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 |
PeerJ (10), pp. |
||||||||
| 10. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. | Khophai, S Thanee, M Techasen, A Namwat, N Klanrit, P Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Loilome, W |
2018 |
OncoTargets and therapy (11), pp. 7019-7029 |
|
| 2. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 |
PloS one 9 (14), pp. e0222140 |
|
| 3. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. | Chanakankun, R Proungvitaya, T Chua-On, D Limpaiboon, T Roytrakul, S Jusakul, A Titapun, A Jarearnrat, A Proungvitaya, S |
2020 |
Oncology letters 1 (19), pp. 930-942 |
|
| 4. | Serum IgG as a Marker for -Associated Cholangiocarcinoma Correlated with HER2 Overexpression. | Titapun, A Techasen, A Sa-Ngiamwibool, P Sithithaworn, P Luvira, V Srisuk, T Jareanrat, A Dokduang, H Loilome, W Thinkhamrop, B Khuntikeo, N |
2020 |
International journal of general medicine (13), pp. 1271-1283 |
|
| 5. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 |
International journal of general medicine (14), pp. 2191-2204 |
|
| 6. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. | Padthaisong, S Phetcharaburanin, J Klanrit, P Li, JV Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Wangwiwatsin, A Mahalapbutr, P Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 30 |
|
| 7. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. | Tomacha, J Dokduang, H Padthaisong, S Namwat, N Klanrit, P Phetcharaburanin, J Wangwiwatsin, A Khampitak, T Koonmee, S Titapun, A Jarearnrat, A Khuntikeo, N Loilome, W |
2021 |
Frontiers in pharmacology (12), pp. 696961 |
|
| 8. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma. | Leeratanakachorn, N Luvira, V Tipwaratorn, T Theeragul, S Jarearnrat, A Titapun, A Srisuk, T Kamsa-Ard, S Pugkhem, A Khuntikeo, N Pairojkul, C Bhudhisawasdi, V |
2021 |
International journal of hepatology (2021), pp. 1625717 |
|
| 9. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. | Kittirat, Y Phetcharaburanin, J Promraksa, B Kulthawatsiri, T Wangwiwatsin, A Klanrit, P Sangkhamanon, S Jarearnrat, A Thongchot, S Mahalapbutr, P Loilome, W Saya, H Namwat, N |
2021 |
Frontiers in public health (9), pp. 766455 |
|
| 10. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M Phetcharaburanin, J Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Vilayhong, V Sa-Ngiamwibool, P Techasen, A Wangwiwatsin, A Mahalapbutr, P Li, JV Loilome, W |
2022 |
Frontiers in public health (10), pp. 766023 |
|
| 11. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 |
Frontiers in public health (10), pp. 816028 |
|
| 12. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. | Sitthirak, S Suksawat, M Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sangkhamanon, S Loilome, W |
2022 |
PeerJ (10), pp. e13876 |
|
| 13. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Loilome, W Wee, A Koonmee, S |
2022 |
Frontiers in medicine (9), pp. 893252 |
|
| 14. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 |
HPB : the official journal of the International Hepato Pancreato Biliary Association 11 (24), pp. 1944-1956 |
|
| 15. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 |
Frontiers in oncology (12), pp. 1004220 |
|
| 16. | Compliance with enhanced recovery after surgery predicts long-term outcome after hepatectomy for cholangiocarcinoma. | Jongkatkorn, C Luvira, V Suwanprinya, C Piampatipan, K Leeratanakachorn, N Tipwaratorn, T Titapun, A Srisuk, T Theeragul, S Jarearnrat, A Thanasukarn, V Pugkhem, A Khuntikeo, N Pairojkul, C Kamsa-Ard, S Bhudhisawasdi, V |
2023 |
World journal of gastrointestinal surgery 3 (15), pp. 362-373 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway | Sasikamon Khophai Malinee Thanee Anchalee Techasen Nisana Namwat Poramate Klanrit Attapol Titapun Apiwat Jarearnrat Prakasit Sa-Ngiamwibool Watcharin Loilome |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 7019.0-7029.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 2. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Manida Suksawat Poramate Klanrit Jutarop Phetcharaburanin Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Prakasit Sa-ngiamwibool Anchalee Techasen Watcharin Loilome |
2019 |
PLOS ONE 9.0 (14.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 3. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Ravinnipa Chanakankun Tanakorn Proungvitaya Daraporn Chua-On Temduang Limpaiboon Sittiruk Roytrakul Apinya Jusakul Attapol Titapun Apiwat Jarearnrat Siriporn Proungvitaya |
2020 |
ONCOLOGY LETTERS 1.0 (19.0), pp. 930.0-942.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 4. | Serum IgG as a Marker for Opisthorchis viverrini-Associated Cholangiocarcinoma Correlated with HER2 Overexpression | Attapol Titapun Anchalee Techasen Prakasit Sa-Ngiamwibool Paiboon Sithithaworn Vor Luvira Tharatip Srisuk Apiwat Jareanrat Hasaya Dokduang Watcharin Loilonne Bandit Thinkhamrop Narong Khuntikeo |
2020 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (13.0), pp. 1271.0-1283.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection | Attapol Titapun Vor Luvira Tharatip Srisuk Apiwat Jareanrat Vasin Thanasukarn Malinee Thanee Prakasit Sa-Ngiamwibool Sureerat Padthaisong Kassaporn Duangkumpha Manida Suksawat Watcharin Loilome Paiboon Sithithaworn Anchalee Techasen Bandit Thinkhamrop Alexa Dzienny Ayse Caglayan David Park Simran Mahmud Narong Khuntikeo |
2021 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (14.0), pp. 2191.0-2204.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma | Natwutpong Leeratanakachorn Vor Luvira Theerawee Tipwaratorn Suapa Theeragul Apiwat Jarearnrat Attapol Titapun Tharatip Srisuk Supot Kamsa-ard Ake Pugkhem Narong Khuntikeo Chawalit Pairojkul Vajarabhongsa Bhudhisawasdi |
2021 |
INTERNATIONAL JOURNAL OF HEPATOLOGY (2021.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma | Sureerat Padthaisong Jutarop Phetcharaburanin Poramate Klanrit Jia Li Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Arporn Wangwiwatsin Panupong Mahalapbutr Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 8. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Yingpinyapat Kittirat Jutarop Phetcharaburanin Bundit Promraksa Thanaporn Kulthawatsiri Arporn Wangwiwatsin Poramate Klanrit Sakkarn Sangkhamanon Apiwat Jarearnrat Suyanee Thongchot Panupong Mahalapbutr Watcharin Loilome Hideyuki Saya Nisana Namwat |
2021 |
FRONTIERS IN PUBLIC HEALTH (9.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 9. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 |
FRONTIERS IN PHARMACOLOGY (12.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|